Autocorrelation of molecular electrostatic potential surface properties combined with partial least squares analysis as new strategy for the prediction of the activity of human A3 adenosine receptor antagonists

被引:36
|
作者
Moro, S
Bacilieri, M
Cacciari, B
Spalluto, G
机构
[1] Univ Padua, Dipartimento Sci Farmaceut, Mol Modeling Sect, I-35131 Padua, Italy
[2] Univ Trieste, Dipartimento Sci Farmaceut, I-34127 Trieste, Italy
[3] Univ Ferrara, Dipartimento Sci Farmaceut, I-44100 Ferrara, Italy
关键词
D O I
10.1021/jm0502440
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The combination of molecular electrostatic potential (MEP) surface properties (autocorrelation vectors) with the conventional partial least squares (PLS) analysis has been used for the prediction of the human A(3) receptor antagonist activities. Three-hundred-fifty-eight structurally diverse human A(3) receptor antagonists have been utilized to generate a novel ligand-based three-dimensional structure -activity relationship. Remarkably, our chemical library includes all 21 important chemical classes of human A(3) antagonists currently discovered, and it represents the largest molecular collection used to generate a general human A3 antagonist structure-activity relationship. A robust quantitative model has been obtained as described by both cross-validated correlation coefficient (r(cv) = 0.81) and prediction capability (r(pred) = 0.82). The proposed MEP/PLS approach can be considered as an alternative hit identification tool in virtual screening applications.
引用
收藏
页码:5698 / 5704
页数:7
相关论文
共 9 条
  • [1] Prediction of the aqueous solvation free energy of organic compounds by using autocorrelation of molecular electrostatic potential surface properties combined with response surface analysis
    Michielan, Lisa
    Bacilieri, Magdalena
    Kaseda, Chosei
    Moro, Stefano
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (10) : 5733 - 5742
  • [2] Response surface analysis as alternative 3D-QSAR tool: Human A3 adenosine receptor antagonists as a key study
    Bacilieri, Magdalena
    Kaseda, Chosei
    Spalluto, Giarnpiero
    Moro, Stefano
    LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (02) : 122 - 127
  • [3] New selective A2A agonists and A3 antagonists for human adenosine receptors: synthesis, biological activity and molecular docking studies
    Rodriguez, Anna
    Guerrero, Angel
    Gutierrez-de-Teran, Hugo
    Rodriguez, David
    Brea, Jose
    Loza, Maria I.
    Rosell, Gloria
    Bosch, M. Pilar
    MEDCHEMCOMM, 2015, 6 (06) : 1178 - 1185
  • [4] Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A3 adenosine receptor antagonists
    Baraldi, PG
    Cacciari, B
    Moro, S
    Spalluto, G
    Pastorin, G
    Da Ros, T
    Klotz, KN
    Varani, K
    Gessi, S
    Borea, PA
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) : 770 - 780
  • [5] Novel potent and highly selective human A3 adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: Molecular docking analysis and pharmacological studies
    Colotta, Vittoria
    Capelli, Francesca
    Lenzi, Ombretta
    Catarzi, Daniela
    Varano, Flavia
    Poli, Daniela
    Vincenzi, Fabrizio
    Varani, Katia
    Borea, Pier Andrea
    Dal Ben, Diego
    Volpini, Rosaria
    Cristalli, Gloria
    Filacchioni, Guido
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (01) : 401 - 410
  • [6] Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation
    Varano, Flavia
    Catarzi, Daniela
    Squarcialupi, Lucia
    Betti, Marco
    Vincenzi, Fabrizio
    Ravani, Annalisa
    Varani, Katia
    Dal Ben, Diego
    Thomas, Ajiroghene
    Volpini, Rosaria
    Colotta, Vittoria
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 96 : 105 - 121
  • [7] 2-Arylpyrazolo[4,3-d]pyrimidin-7-amino Derivatives As New Potent and Selective Human A3 Adenosine Receptor Antagonists. Molecular Modeling Studies and Pharmacological Evaluation
    Squarcialupi, Lucia
    Colotta, Vittoria
    Catarzi, Daniela
    Varano, Flavia
    Filacchioni, Guido
    Varani, Katia
    Corciulo, Carmen
    Vincenzi, Fabrizio
    Borea, Pier Andrea
    Ghelardini, Carla
    Mannelli, Lorenzo Di Cesare
    Ciancetta, Antonella
    Moro, Stefano
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (06) : 2256 - 2269
  • [8] Exploring the Directionality of 5-Substitutions in a New Series of 5-Alkylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine as a Strategy To Design Novel Human A3 Adenosine Receptor Antagonists
    Federico, Stephanie
    Ciancetta, Antonella
    Sabbadin, Davide
    Paoletta, Silvia
    Pastorin, Giorgia
    Cacciari, Barbara
    Klotz, Karl Norbert
    Moro, Stefano
    Spalluto, Giampiero
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9654 - 9668
  • [9] Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists.: Influence of the heteroaryl substituent on binding affinity and molecular modeling investigations
    Pastorin, G
    Da Ros, T
    Bolcato, C
    Montopoli, C
    Moro, S
    Cacciari, B
    Baraldi, PG
    Varani, K
    Borea, PA
    Spalluto, G
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (05) : 1720 - 1729